SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-015940
Filing Date
2023-05-09
Accepted
2023-05-09 16:05:41
Documents
58
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 619322
2 ex10-1.htm EX-10.1 19103
3 ex31-1.htm EX-31.1 18047
4 ex31-2.htm EX-31.2 20628
5 ex32-1.htm EX-32.1 7276
6 ex32-2.htm EX-32.2 7344
  Complete submission text file 0001493152-23-015940.txt   3524023

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE ltrn-20230331.xsd EX-101.SCH 27311
8 XBRL CALCULATION FILE ltrn-20230331_cal.xml EX-101.CAL 46685
9 XBRL DEFINITION FILE ltrn-20230331_def.xml EX-101.DEF 89942
10 XBRL LABEL FILE ltrn-20230331_lab.xml EX-101.LAB 241809
11 XBRL PRESENTATION FILE ltrn-20230331_pre.xml EX-101.PRE 189768
52 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 435205
Mailing Address 1920 MCKINNEY AVENUE 7TH FLOOR DALLAS TX 75201
Business Address 1920 MCKINNEY AVENUE 7TH FLOOR DALLAS TX 75201 972-277-1136
Lantern Pharma Inc. (Filer) CIK: 0001763950 (see all company filings)

IRS No.: 463973463 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39318 | Film No.: 23901894
SIC: 2834 Pharmaceutical Preparations